Sharenet Sites 
Sharenet Sites
Directorate change
Mediclinic International plc
(Incorporated in England and Wales)
Company Number 8338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
(“Mediclinic” or “the Company”)
22 February 2017
DIRECTORATE CHANGE
The Company announces that Mr Ian Tyler, the Company’s Senior Independent Director, resigned as
a director of the Company with effect from 21 February 2017.
Ian Tyler was appointed as an independent non-executive director and Chairman of Al Noor Hospitals
Group plc (“Al Noor”) on 5 June 2013 prior to its successful IPO and listing on the London Stock
Exchange on 21 June 2013. In 2015 he was instrumental in leading this group through the
combination with Mediclinic International Limited. Subsequent to the combination, he was appointed
as the Senior Independent Director of Mediclinic International plc on 15 February 2016.
Mr Desmond Smith has been appointed as the Senior Independent Director, in the place of Ian Tyler.
Desmond Smith was appointed an independent non-executive director of Mediclinic International
Limited in 2008 and Lead Independent Director in 2010. He was appointed an independent non-
executive director of the Company subsequent to the combination of Al Noor and Mediclinic
International Limited. Desmond Smith is Chairman of Mediclinic’s Audit and Risk Committee and a
member of the Nomination Committee. He is also Chairman of the Sanlam Group and the
Reinsurance Group of America (South Africa).
This announcement is made in accordance with the requirement of LR 9.6.11.
Mediclinic’s primary listing is on the Main Market of the LSE, with secondary listings on the JSE in
South Africa and on the NSX in Namibia.
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
For further information please contact:
Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
Capita Company Secretarial Services Limited
Victoria Dalby
+44 (0)207 954 9600
Date: 22/02/2017 02:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
